LOUIS HACHETTE 1.590 € (-3,64 %)
EMEIS 15.320 € (+0,20 %)
PLANISWARE 18.060 € (+1,12 %)
FDJ UNITED 22.930 € (-0,22 %)
FERMENTALG 0.589 € (-1,17 %)
EXOSENS 62.800 € (-2,41 %)
ABL Diagnostics 2.300 € (0,00 %)
GALP ENERGIA-NOM 18.975 € (-1,66 %)
REN 3.715 € (-0,80 %)
LVMH 481.250 € (+1,53 %)
AIRBUS 188.600 € (+0,05 %)
SAFRAN 298.000 € (+0,44 %)
VEOLIA ENVIRON. 36.330 € (+0,36 %)
FORVIA 10.685 € (+1,96 %)
ASML HOLDING 1 330.200 € (+1,93 %)
ARVERNE GROUP 6.200 € (0,00 %)
HERMES INTL 1 710.500 € (+2,33 %)
SANOFI 73.650 € (-1,33 %)
TRIGANO 159.600 € (+4,52 %)
UNIBAIL-RODAMCO-WE 102.900 € (-1,39 %)
CRCAM BRIE PIC2CCI 33.605 € (+0,93 %)
AIR LIQUIDE 177.660 € (-1,45 %)
THALES 238.600 € (-1,00 %)
STELLANTIS NV 6.522 € (+0,71 %)
EDP 4.415 € (+1,47 %)
SERGEFERRARI GROUP 6.860 € (+1,18 %)
STMICROELECTRONICS 48.855 € (+0,73 %)
VOPAK 44.820 € (+1,54 %)
RELX 28.560 € (-5,93 %)
AXA 41.620 € (-0,43 %)
PHARMING GROUP 1.129 € (-19,10 %)
FLEURY MICHON 22.000 € (0,00 %)
CREDIT AGRICOLE 17.295 € (+0,26 %)
ABIVAX 109.600 € (-0,54 %)
CAPGEMINI 103.800 € (-1,10 %)
SOITEC 151.550 € (+3,20 %)
AMG 39.180 € (+4,09 %)
NOS, SGPS 5.205 € (0,00 %)
ADYEN 958.100 € (+0,05 %)
ASM INTERNATIONAL 872.800 € (+0,16 %)
UNILEVER 50.490 € (-0,34 %)
MOTA ENGIL 4.956 € (+1,27 %)
L'OREAL 373.150 € (-0,07 %)
RENAULT 31.280 € (+1,89 %)
WORLDLINE 0.249 € (+0,24 %)
NOVACYT 0.374 € (+8,88 %)
SHELL PLC 36.385 € (-2,06 %)
ACCOR 45.470 € (+1,95 %)
SCHNEIDER ELECTRIC 284.500 € (+0,64 %)
PROSUS 42.135 € (+0,61 %)
AIR FRANCE -KLM 10.520 € (+2,09 %)
TIKEHAU CAPITAL 17.680 € (0,00 %)
SAINT GOBAIN 81.520 € (+1,60 %)
CARREFOUR 17.095 € (-0,26 %)
PLUXEE 12.450 € (-0,56 %)
EUROPLASMA 0.007 € (+6,06 %)
VINCI 133.250 € (-0,19 %)
SARTORIUS STED BIO 166.000 € (-0,72 %)
PHILIPS KON 23.580 € (+1,86 %)
TOTALENERGIES 75.660 € (-1,42 %) |
16/04/2026 07:30
Inside Information / News release on accounts, resultsQ3 FY26 Sales IMPROVING MOMENTUM WITH STABLE ORGANIC NET SALES IN Q3 IN A VOLATILE CONTEXTQ3 FY26 ORGANIC NET SALES +0.1% (-14.6% REPORTED) We report as expected, a sequential improvement in Organic Net Sales in Q3 compared to H1, with total group volumes in Q3 back to growth at +4%, and with Strategic International Brands’ volumes growing +3%. When excluding the US and China markets which contracted in Q3 -12% and -7% respectively, Q3 Organic Net Sales in the rest of the world are growing strongly at +5%. Sales have improved in markets across all regions in Q3, with strong momentum in Emerging Markets and continued growth in several Mature Markets. We are exploiting evolving consumer trends to capture growth with actions that address consumer trends and needs including:
We are actively managing what is within our control, adapting our resources with agility, deploying our efficiency program, steering the organisation to fuel our future growth and optimise our cash generation. FY26 Q3 Net Sales totalled €1,945m, an organic growth of +0.1%, and -14.6% reported. FY26 9M Net Sales totalled €7,199m, an organic decline of -4.4% and -14.8% reported, with unfavourable Foreign Exchange impact of -€515m mainly linked to USD, INR and TRY1, and Group Structure of -€393m mainly linked to the disposal of Wines & Imperial Blue business. By regions, (Organic Net Sales Q3/YTD):
Asia-RoW +6% / -2%,
Europe +1% / -2%,
Global Travel Retail +11% / +2%,
By brands, (Organic Net Sales Q3/YTD):
FY26 OutlookIn a context that remains volatile and uncertain, we continue to see FY26 as a transition year with improving trends in H2. In line with our expectations, Net Sales strongly improved in Q3. Given the ongoing conflict in the Middle East, we now expect organic net sales to decline by -3% to -4% for the full year. We continue to invest to increase our brands’ desirability with sharp allocation, efficiency, innovation and experiences with A&P investment ratio expected to remain at c.16%. We will continue to defend our Organic Operating Margin to the fullest extent possible, supported by strict cost control and the implementation of our FY26 to FY29 €1bn Operational Efficiencies program, including the adaptation of our “fit for future” organisation. We expect to deliver one third by the end of the fiscal year. Focus on cash generation to continue, with strategic investments now expected to be below €700m and strong operating working capital management. Aiming for c.80% and above cash conversion from FY26. FX impact expected to be significantly negative1 Medium Term FY27-29Leveraging our unique broad-based and balanced geographic breadth and diversified portfolio of premium international spirits Projecting Organic Net Sales growth, aiming for the range of +3% to +6% p.a2 on average, with annual Organic Operating Margin expansion Anticipating organic margin expansion to be supported by efficiencies of €1bn from FY26 to FY29, with program to optimize Operations and implement a Fit For Future organisational structure Maintaining consistent investments behind our brands with c.16% A&P/Net Sales, with agility and responsiveness to maximise opportunity by brand and market Strong cash generation aiming for c.80% and above cash conversion to fund our financial policy priorities, with strategic investments1 normalizing to no more than c.€800m p.a. Our intention is to delever and to bring our net debt / EBITDA ratio below 3x by FY29 We are confident in our strategy, in our operating model and in the engagement of our teams, to deliver sustainable value growth over time DividendAn interim dividend of €2.35 per share will be detached on July 22nd and paid on July 24th. The final dividend will be subject to the AGM decision on November 20th. All growth data specified in this press release refers to organic growth (at constant FX and Group structure), unless otherwise stated. Data may be subject to rounding. Definitions and reconciliation of non-IFRS measures to IFRS measuresPernod Ricard’s management process is based on the following non-IFRS measures which are chosen for planning and reporting. The Group’s management believes these measures provide valuable additional information for users of the financial statements in understanding the Group’s performance. These non-IFRS measures should be considered as complementary to the comparable IFRS measures and reported movements therein. Organic growth
Profit from recurring operationsProfit from recurring operations corresponds to the operating profit excluding other non-recurring operating income and expenses. Cash ConversionCash conversion is calculated by dividing the Recurring Operating Cash Flow by the Profit from recurring operations. The Recurring Operating Cash Flow is calculated as the Self-financing capacity from Recurring Operations + Change in Recurring Operating Working Capital needs, Change in Strategic inventories and Cash Capex. Net Debt / EBITDANet debt corresponds to gross financial debt, including IFRS 16 lease liabilities, less cash and cash equivalents. EBITDA corresponds to Profit from recurring operations excluding depreciation, and amortisation on fixed assets. The net debt / EBITDA ratio is calculated using EBITDA on a last-twelve-months basis and using Net Debt translated at last-twelve-months average exchange rates. About Pernod RicardPernod Ricard is a worldwide leader in the spirits and wine industry, blending traditional craftsmanship, state-of-the-art brand-building, and global distribution technologies. Our prestigious portfolio of premium to luxury brands includes Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière